This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Drugs Against Protozoan Parasites: Target Selection, Structural Biology and Medicinal Chemistry
joint with Molecular Helminthology: An Integrated Approach
Organizer(s): Margaret A. Phillips, Pradipsinh K. Rathod and William N. Hunter
Date: April 09 - 13, 2005
Location: Copper Mountain Resort, Copper Mountain, CO, USA
Part of the Global Health Series, Supported by the Bill & Melinda Gates Foundation and Sponsored by the International Center for Tropical Disease Research
Summary of Meeting:
Appreciate important issues in parasite drug development: Hundreds of millions of people worldwide suffer from diseases caused by protozoan parasites. Effective drugs are lacking for sleeping sickness and leishmaniasis, and current therapies for treating malaria are at risk due to drug resistance. Thus, the development of new lines of anti-protozoan agents is urgently needed. With the sequencing of genomes of organisms responsible for malaria, sleeping sickness, and leishmaniasis, this is an exciting time for the discovery and evaluation of new drug targets, especially when combined with structural biology, combinatorial chemistry, and parasite genetics. Groups of talks, given by chemists, structural biologists, and parasitologists, will exemplify the power of multi-disciplinary collaborations. Experts in drug development outside of parasitology will also be invited in an effort to stimulate their interests in tropical medicine and to learn from their experiences.
Scholarship Deadline: December 8 2004
Discounted Abstract Deadline: December 8 2004
Discounted Registration Deadline: February 9 2005
We gratefully acknowledge additional support for this conference from:
Bill & Melinda Gates FoundationBurroughs Wellcome FundInstitute for OneWorld HealthInternational Center for Tropical Disease ResearchThe Ellison Medical Foundation
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

GlaxoSmithKline

Merck Research Laboratories
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 U13 AI60000-01

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13-AI063800-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found